Result of General Meeting and Total Voting Rights

29th March 2021

London, UK – 29 March 2021: Nuformix plc (LSE:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, confirms that, further to the announcement made in connection with the Placing on 10 March 2021, at the General Meeting held earlier today all Resolutions put to Shareholders were duly passed. Download News

Back to all News